Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rolyn Alvarado
Pazopanib as First Line Treatment for Solitary Fibrous Tumours: The Royal Marsden Hospital Experience
Clinical Sarcoma Research
Oncology
Related publications
Retroperitoneal Solitary Fibrous Tumor: Surgery as First Line Therapy
Clinical Sarcoma Research
Oncology
Pazopanib in the Treatment of Advanced Solitary Fibrous Tumour – Authors' Reply
The Lancet Oncology
Oncology
Prognostic Factors and Treatment Outcomes in Patients With Small Bowel Adenocarcinoma (SBA): The Royal Marsden Hospital (RMH) Experience
BMC Cancer
Cancer Research
Oncology
Genetics
Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Second Experience
American Journal of Hematology
Hematology
Clinical Benefit of Patients With Advanced Adrenocortical Carcinoma (Acc) Treated in Phase I Clinical Trials: The Royal Marsden Hospital (Rmh) Experience
Endocrine Abstracts
Ruxolitinib as First-Line Treatment in Secondary Hemophagocytic Lymphohistiocytosis: A Single Patient Experience
American Journal of Hematology
Hematology
Pazopanib as a Second Line Treatment for Uterine and Ovarian Carcinosarcoma: A Single Institutional Study
Journal of Gynecologic Oncology
Medicine
Gynecology
Oncology
Obstetrics
Angiogenesis Genotyping in the Selection of First-Line Treatment With Either Sunitinib or Pazopanib for Advanced Renal Cell Carcinoma
Oncotarget
Oncology
Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
